12:00 AM
 | 
Feb 13, 2014
 |  BC Innovations  |  Distillery Therapeutics

Indication: Musculoskeletal disease

This week in therapeutics
Indication Target/marker/pathway Summary Licensing status Publication and contact information
Musculoskeletal disease
Osteoporosis Lysophosphatidic acid receptor 1 (LPAR1; EDG2; LPA1) In vitro and...

Read the full 223 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >